Researchers are excited about Retatrutide , a novel dual compound showing promising outcomes in initial trials for body loss . It works by modulating both pathways : GLP-1 and GIP, that , when activated , assist influence cravings and boost metabolism . Initial findings demonstrate considerable body reduction and possible improvements for patients